AgomAb Therapeutics NV ADR (AGMB) Live Share Price, Invest From India

AgomAb Therapeutics NV ADR Stock Performance

as on September 26, 2026 at 2:15 pm IST

Day's Low
Day's High
$10.41
Day's Price Range
$11.23
$10.51
0.95%
Downside
6.85%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$10.51
100.00%
Downside
-100.00%
Upside

AgomAb Therapeutics NV ADR share price movements today

Previous Close: $10.58
Open: $10.66
Volume: 552.1K
Market Cap: $521.0M
Day's Low - High: $10.41 - $11.23

AgomAb Therapeutics NV ADR Historical Returns

1 Month Return: -26.4 %
3 Month Return: -23.9 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

AgomAb Therapeutics NV ADR Stock Fundamentals & Key Indicators

Check AgomAb Therapeutics NV ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$521.0M

EPS (TTM)

-0.79

Dividend Yield

0.00%

PE Ratio (TTM)

-11.77

Industry PE ratio

-8.07

PEG Ratio

-0.11773263291139241

Return On Equity TTM

-19.70%

AgomAb Therapeutics NV ADR Stock Valuation

Track how AgomAb Therapeutics NV ADR P/E has moved over time to understand its valuation trends.

AgomAb Therapeutics NV ADR in the last 1 year

Overview
Trends

Lowest (-9.74x)

March 31, 2026

Today (-9.74x)

March 31, 2026

Industry (-8.07x)

March 31, 2026

Highest (-9.74x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: -9.74x

AgomAb Therapeutics NV ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of AgomAb Therapeutics NV ADR with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
AgomAb Therapeutics NV ADR	StrongBuy	$521.0M	NA	-11.77	0.00%	0.00%
Moderna	Neutral	$77.8B	-53.76%	-24.41	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.4B	186.58%	30.16	86.04%	0.00%
Regeneron	Buy	$82.8B	23.34%	19.01	84.86%	0.46%

Analyst Recommendation on AgomAb Therapeutics NV ADR Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for AgomAb Therapeutics NV ADR. Average target price of $47.5

Indian Investors' Interest in AgomAb Therapeutics NV ADR Stock

Search interest for AgomAb Therapeutics NV ADR Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 28, 2026 to September 27, 2026

Change:33% versus previous 30 day period

AgomAb Therapeutics NV ADR Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Sep 2025	Mar 2026
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	-11	-15	-16
EBITDA	-11	-18	-17
Interest Expense	-	0	-
Depreciation	0	0	0
Income Before Tax	-11	-18	-17
Income Tax Expense	0	-	-
Net Income	-11	-18	-17
Net Profit Margin	0.00%	0.00%	0.00%

AgomAb Therapeutics NV ADR Annual Profit & Loss

All numbers in Millions USD

	Mar 2026
Total Revenue	-
Gross Profit	-
Operating Income	-59
EBITDA	-62
Interest Expense	0
Depreciation	0
Income Before Tax	-62
Income Tax Expense	-
Net Income	-62
Net Profit Margin	0.00%

AgomAb Therapeutics NV ADR Quarterly Cash Flow

All numbers in Millions USD

	Dec 2024	Sep 2025	Mar 2026
Net Income	-11	-18	-17
Operating Cash Flow	-12	-13	-13
Investing Cash Flow	0	-	-30
Financing Cash Flow	81	0	0
Change in Cash	68	-13	-43

AgomAb Therapeutics NV ADR Annual Cash Flow

All numbers in Millions USD

	Mar 2026
Net Income	-62
Operating Cash Flow	-51
Investing Cash Flow	-33
Financing Cash Flow	0
Change in Cash	-85

Mutual Funds that own AgomAb Therapeutics NV ADR Stock

Check out the Mutual Funds with significant holdings in AgomAb Therapeutics NV ADR.

Funds	Holdings	Shares Held
Federated Hermes Equity Funds	3.242553%	1596892

Global Institutional Holdings in AgomAb Therapeutics NV ADR

Funds	Holdings
Federated Hermes Equity Funds	3.24%
Joseph Edelman	1.22%
ALPS	0.13%

Insights on AgomAb Therapeutics NV ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, AGMB stock has moved down by -13.6%

About AgomAb Therapeutics NV ADR

AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist. Its innovative pipeline features several promising candidates, including Ontunisertib (AGMB-129), an orally administered, gastrointestinal-restricted small molecule inhibitor targeting ALK5 or TGFßR1, designed to treat Fibrostenosing Crohn's disease and presently undergoing Phase 2a clinical trials. Also in development is AGMB-447, an inhaled small molecule that similarly inhibits ALK5 or TGFßR1, intended for idiopathic pulmonary fibrosis and currently in Phase 1 clinical studies. Furthermore, the company is advancing AGMB-101, a monoclonal antibody designed to mimic HGF. This agent exerts its effects through the agonism or stimulation of the MET receptor, having demonstrated both antifibrotic and regenerative capabilities in preclinical models. Established in 2017, AgomAb Therapeutics maintains its headquarters in Antwerp, Belgium.

Organisation	AgomAb Therapeutics NV ADR
Headquarters	Posthoflei 1/6, Antwerp, VL, 2600, BE
Industry	Biotechnology
CEO	Tim Knotnerus
E-voting on shares	Click here to vote

Key Management of AgomAb Therapeutics NV ADR

Name	Title
Mr. Paolo Michieli Ph.D.	Founder, Senior Advisor & Member of Scientific Advisory Board
Mr. Pierre Kemula B.Sc.	Chief Financial Officer
Sofie Van Gijsel	Vice President of Investor Relations
Ms. Ellen Lefever	General Counsel
Dr. Philippe Wiesel M.D.	Chief Medical Officer
Dr. Paul Van Der Horst Ph.D.	Chief Business Officer
Dr. Andrea Sáez Borderías Ph.D.	Chief Development Officer
Dr. Tim Knotnerus MSc, Ph.D.	CEO & Executive Director

FAQs

What is AgomAb Therapeutics NV ADR share price today?

AgomAb Therapeutics NV ADR share price today is $10.51 as on September 26, 2026 at 8:45 am IST at the close of the market. AgomAb Therapeutics NV ADR share today touched a day high of $11.23 and a low of $10.41.

What is the 52 week high and 52 week low for AgomAb Therapeutics NV ADR share?

AgomAb Therapeutics NV ADR share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. AgomAb Therapeutics NV ADR stock price today i.e. September 26, 2026 at 8:45 am IST is closed at $10.51,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is AgomAb Therapeutics NV ADR's market capitalisation today?

AgomAb Therapeutics NV ADR market capitalisation is $0.00T as on September 26, 2026 at 8:45 am IST.

How to invest in AgomAb Therapeutics NV ADR Stock (AGMB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for AgomAb Therapeutics NV ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AgomAb Therapeutics NV ADR Shares that will get you 0.1427 shares as per AgomAb Therapeutics NV ADR share price of $10.51 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy AgomAb Therapeutics NV ADR Stock (AGMB) from India?

Indian investors can start investing in AgomAb Therapeutics NV ADR (AGMB) shares with as little as ₹95.819999694824 or $1 (as of September 27, 2026 at 3:46 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in AgomAb Therapeutics NV ADR stock (as per the Rupee-Dollar exchange rate as on September 27, 2026 at 3:46 pm IST). Based on AgomAb Therapeutics NV ADR share’s latest price of $10.51 as on September 26, 2026 at 8:45 am IST, you will get 0.9515 shares of AgomAb Therapeutics NV ADR. Learn more about fractional shares .